US3482015A
(en)
*
|
1965-02-08 |
1969-12-02 |
Merck & Co Inc |
Aerosol composition of phenylephrine tartrate and the production of such
|
US3282791A
(en)
*
|
1965-08-17 |
1966-11-01 |
Merck & Co Inc |
Inhalation aerosol suspension of anhydrous disodium dexamethasone phosphate, propellents, and sorbitan trioleate
|
US3897779A
(en)
*
|
1973-06-27 |
1975-08-05 |
American Cyanamid Co |
Triamcinolone acetonide inhalation therapy
|
US3985868A
(en)
*
|
1973-06-27 |
1976-10-12 |
American Cyanamid Company |
Asthma treatment by inhalation of micronized N,N-diethyl-4-methyl-1-piperazinecarboxamide pamoate
|
EP0091313A2
(en)
*
|
1982-04-05 |
1983-10-12 |
Alcon Laboratories, Inc. |
Perfluorohydrocarbons as vehicles for administering drugs
|
EP0091313A3
(en)
*
|
1982-04-05 |
1985-05-22 |
Alcon Laboratories Inc |
Perfluorohydrocarbons as vehicles for administering drugs
|
US4581225A
(en)
*
|
1984-04-25 |
1986-04-08 |
Eli Lilly And Company |
Sustained release intranasal formulation and method of use thereof
|
US5695743A
(en)
*
|
1988-12-06 |
1997-12-09 |
Riker Laboratories, Inc. |
Medicinal aerosol formulations
|
US5605674A
(en)
*
|
1988-12-06 |
1997-02-25 |
Riker Laboratories, Inc. |
Medicinal aerosol formulations
|
US5683677A
(en)
*
|
1988-12-06 |
1997-11-04 |
Riker Laboratories, Inc. |
Medicinal aerosol formulations
|
US5674473A
(en)
*
|
1988-12-06 |
1997-10-07 |
Riker Laboratories, Inc. |
Medicinal aerosol formulations
|
US5720940A
(en)
*
|
1988-12-06 |
1998-02-24 |
Riker Laboratories, Inc. |
Medicinal aerosol formulations
|
US5766573A
(en)
*
|
1988-12-06 |
1998-06-16 |
Riker Laboratories, Inc. |
Medicinal aerosol formulations
|
US5681545A
(en)
*
|
1988-12-06 |
1997-10-28 |
Riker Laboratories, Inc. |
Medicinal aerosol formulations
|
US6352684B1
(en)
|
1988-12-06 |
2002-03-05 |
Riker Laboratories Inc. |
CRC-free medicinal aerosol formulations of 1,1,1,2-tetrafluoroethane (134A) with polar adjuvant
|
US5439670A
(en)
*
|
1989-11-28 |
1995-08-08 |
Riker Laboratories, Inc. |
Medicinal aerosol formulations
|
US7160538B2
(en)
|
1990-02-03 |
2007-01-09 |
Boehringer Ingelheim Kg |
Suspension aerosol formulations of pharmaceutical products
|
US20050031548A1
(en)
*
|
1990-02-03 |
2005-02-10 |
Boehringer Ingelheim Kg |
Suspension aerosol formulations of pharmaceutical products
|
US20110014134A1
(en)
*
|
1990-02-03 |
2011-01-20 |
Boehringer Ingelheim Kg |
Suspension aerosol formulations of pharmaceutical products
|
US20090104127A1
(en)
*
|
1990-02-03 |
2009-04-23 |
Boehringer Ingelheim Kg |
Suspension aerosol formulations of pharmaceutical products
|
US5919435A
(en)
*
|
1990-11-09 |
1999-07-06 |
Glaxo Group Limited |
Aerosol formulation containing a particulate medicament
|
US5785952A
(en)
*
|
1990-11-09 |
1998-07-28 |
Glaxo Group Limited |
Aerosol medicament formulation having a surface coating of surfactant
|
US6306368B1
(en)
|
1990-11-09 |
2001-10-23 |
Glaxo Group Limited |
Aerosol formulation containing a particulate medicament
|
US6251368B1
(en)
|
1991-12-12 |
2001-06-26 |
Glaxo Group Limited |
Pharmaceutical aerosol formulation containing a particulate medicament, a propellant and substantially free of a surfactant
|
US5674472A
(en)
*
|
1991-12-12 |
1997-10-07 |
Glaxo Group Limited |
Canisters containing aerosol formulations containing P134a and fluticasone propionate
|
US5817293A
(en)
*
|
1991-12-12 |
1998-10-06 |
Glaxo Group Limited |
Canister containing aerosol formulations containing P134a and particulate medicaments
|
US5922306A
(en)
*
|
1991-12-12 |
1999-07-13 |
Glaxo Group Limited |
Aerosol formulations containing P134a and particulate medicament
|
US6200549B1
(en)
|
1991-12-12 |
2001-03-13 |
Glaxo Group Limited |
Aerosol formulation containing P134a and particulate medicament
|
US6221339B1
(en)
|
1991-12-12 |
2001-04-24 |
Glaxo Group Limited |
Medicaments
|
US6238647B1
(en)
|
1991-12-12 |
2001-05-29 |
Glaxo Group Limited |
Aerosol formulations containing salmeterol xinafoate, an anticholinergic agent and tetrafluoroethane
|
US5736124A
(en)
*
|
1991-12-12 |
1998-04-07 |
Glaxo Group Limited |
Aerosol formulations containing P134a and particulate medicament
|
US6303103B1
(en)
|
1991-12-12 |
2001-10-16 |
Glaxo Group Limited |
Aerosols containing salmeterol xinafoate and an anticholinergic medicament
|
US5683676A
(en)
*
|
1991-12-12 |
1997-11-04 |
Glaxo Group Limited |
Canister containing aerosol formulations containing P134a and particulate medicaments
|
US6306369B1
(en)
|
1991-12-12 |
2001-10-23 |
Glaxo Group Limited |
Aerosol formulations containing P134a and particulate medicament
|
US6333023B1
(en)
|
1991-12-12 |
2001-12-25 |
Glaxo Group Limited |
Aerosol formulation containing particulate formoterol, propellant and polar cosolvent
|
US5676929A
(en)
*
|
1991-12-12 |
1997-10-14 |
Glaxo Group Limited |
Canister containing aerosol formulations containing P134a and particulate medicaments
|
US5653962A
(en)
*
|
1991-12-12 |
1997-08-05 |
Glaxo Group Limited |
Aerosol formulations containing P134a and particulate medicaments
|
US20050089477A1
(en)
*
|
1991-12-12 |
2005-04-28 |
Glaxo Group Limited |
Medicaments
|
EP1066828B2
(en)
†
|
1991-12-12 |
2006-12-06 |
Glaxo Group Limited |
Aerosol compositions
|
US6893628B2
(en)
|
1991-12-12 |
2005-05-17 |
Glaxo Group Limited |
Aerosol formulations containing P134a and particulate medicament
|
US6919069B2
(en)
|
1991-12-12 |
2005-07-19 |
Glaxo Group Limited |
Aerosol formulation containing particulate formoterol, propellant and polar cosolvent
|
US7498020B2
(en)
|
1991-12-12 |
2009-03-03 |
Glaxo Group Limited |
Medicaments
|
US5744123A
(en)
*
|
1991-12-12 |
1998-04-28 |
Glaxo Group Limited |
Aerosol formulations containing P134a and particulate medicaments
|
US20030143163A1
(en)
*
|
1991-12-12 |
2003-07-31 |
Glaxo Group Limited |
Medicaments
|
US20030165437A1
(en)
*
|
1991-12-12 |
2003-09-04 |
Glaxo Group Limited |
Aerosos formulations containing P134a and particulate medicament
|
US20030198600A1
(en)
*
|
1991-12-12 |
2003-10-23 |
Glaxo Group Limited |
Aerosol formulation containing particulate formoterol, propellant and polar cosolvent
|
US20050207991A1
(en)
*
|
1991-12-12 |
2005-09-22 |
Glaxo Group Limited |
Aerosol formulations containing P134a and particulate medicament
|
US5674471A
(en)
*
|
1991-12-12 |
1997-10-07 |
Glaxo Group Limited |
Aerosol formulations containing P134a and salbutamol
|
US20090188491A1
(en)
*
|
1991-12-12 |
2009-07-30 |
Glaxo Group Limited |
Medicaments
|
US20050232873A1
(en)
*
|
1991-12-12 |
2005-10-20 |
Glaxo Group Limited |
Aerosol formulation containing particulate formoterol, propellant and polar cosolvent
|
US5658549A
(en)
*
|
1991-12-12 |
1997-08-19 |
Glaxo Group Limited |
Aerosol formulations containing propellant 134a and fluticasone propionate
|
US6743413B1
(en)
|
1991-12-18 |
2004-06-01 |
3M Company |
Suspension aerosol formulations
|
US7101534B1
(en)
|
1991-12-18 |
2006-09-05 |
3M Innovative Properties Company |
Suspension aerosol formulations
|
US7105152B1
(en)
|
1991-12-18 |
2006-09-12 |
3M Innovative Properties Company |
Suspension aerosol formulations
|
US20040197273A1
(en)
*
|
1991-12-18 |
2004-10-07 |
3M Company |
Suspension aerosol formulations
|
US5916540A
(en)
*
|
1994-10-24 |
1999-06-29 |
Glaxo Group Limited |
Aerosol formulations containing P134A and/or P227 and particulate medicament
|
US5603918A
(en)
*
|
1995-06-09 |
1997-02-18 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Aerosol composition of a salt of ipratropium and a salt of albuterol
|
US20030232876A1
(en)
*
|
1996-08-16 |
2003-12-18 |
Pozen, Inc. |
Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
|
US7771352B2
(en)
|
1997-03-04 |
2010-08-10 |
Dexcom, Inc. |
Low oxygen in vivo analyte sensor
|
US9155496B2
(en)
|
1997-03-04 |
2015-10-13 |
Dexcom, Inc. |
Low oxygen in vivo analyte sensor
|
US7901354B2
(en)
|
1997-03-04 |
2011-03-08 |
Dexcom, Inc. |
Low oxygen in vivo analyte sensor
|
US8649841B2
(en)
|
1998-04-30 |
2014-02-11 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US9066695B2
(en)
|
1998-04-30 |
2015-06-30 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8273022B2
(en)
|
1998-04-30 |
2012-09-25 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US10478108B2
(en)
|
1998-04-30 |
2019-11-19 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8622906B2
(en)
|
1998-04-30 |
2014-01-07 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8265726B2
(en)
|
1998-04-30 |
2012-09-11 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8641619B2
(en)
|
1998-04-30 |
2014-02-04 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8260392B2
(en)
|
1998-04-30 |
2012-09-04 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8255031B2
(en)
|
1998-04-30 |
2012-08-28 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8617071B2
(en)
|
1998-04-30 |
2013-12-31 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8391945B2
(en)
|
1998-04-30 |
2013-03-05 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US20080076997A1
(en)
*
|
1998-04-30 |
2008-03-27 |
Abbott Diabetes Care, Inc. |
Analyte monitoring device and methods of use
|
US8235896B2
(en)
|
1998-04-30 |
2012-08-07 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8660627B2
(en)
|
1998-04-30 |
2014-02-25 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8666469B2
(en)
|
1998-04-30 |
2014-03-04 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8670815B2
(en)
|
1998-04-30 |
2014-03-11 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8231532B2
(en)
|
1998-04-30 |
2012-07-31 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8226555B2
(en)
|
1998-04-30 |
2012-07-24 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8380273B2
(en)
|
1998-04-30 |
2013-02-19 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8226557B2
(en)
|
1998-04-30 |
2012-07-24 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8612159B2
(en)
|
1998-04-30 |
2013-12-17 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8226558B2
(en)
|
1998-04-30 |
2012-07-24 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8597189B2
(en)
|
1998-04-30 |
2013-12-03 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8409131B2
(en)
|
1998-04-30 |
2013-04-02 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8287454B2
(en)
|
1998-04-30 |
2012-10-16 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US9326714B2
(en)
|
1998-04-30 |
2016-05-03 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8480580B2
(en)
|
1998-04-30 |
2013-07-09 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8306598B2
(en)
|
1998-04-30 |
2012-11-06 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8473021B2
(en)
|
1998-04-30 |
2013-06-25 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8672844B2
(en)
|
1998-04-30 |
2014-03-18 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8224413B2
(en)
|
1998-04-30 |
2012-07-17 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8688188B2
(en)
|
1998-04-30 |
2014-04-01 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8177716B2
(en)
|
1998-04-30 |
2012-05-15 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8175673B2
(en)
|
1998-04-30 |
2012-05-08 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8738109B2
(en)
|
1998-04-30 |
2014-05-27 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8734348B2
(en)
|
1998-04-30 |
2014-05-27 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8162829B2
(en)
|
1998-04-30 |
2012-04-24 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8734346B2
(en)
|
1998-04-30 |
2014-05-27 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8744545B2
(en)
|
1998-04-30 |
2014-06-03 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8372005B2
(en)
|
1998-04-30 |
2013-02-12 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8366614B2
(en)
|
1998-04-30 |
2013-02-05 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8774887B2
(en)
|
1998-04-30 |
2014-07-08 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8465425B2
(en)
|
1998-04-30 |
2013-06-18 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8840553B2
(en)
|
1998-04-30 |
2014-09-23 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8880137B2
(en)
|
1998-04-30 |
2014-11-04 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8974386B2
(en)
|
1998-04-30 |
2015-03-10 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8346337B2
(en)
|
1998-04-30 |
2013-01-01 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US7885699B2
(en)
|
1998-04-30 |
2011-02-08 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8346336B2
(en)
|
1998-04-30 |
2013-01-01 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US7869853B1
(en)
|
1998-04-30 |
2011-01-11 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US9011331B2
(en)
|
1998-04-30 |
2015-04-21 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US7860544B2
(en)
|
1998-04-30 |
2010-12-28 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US20100312078A1
(en)
*
|
1998-04-30 |
2010-12-09 |
Abbott Diabetes Care Inc. |
Analyte Monitoring Device and Methods of Use
|
US9014773B2
(en)
|
1998-04-30 |
2015-04-21 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8353829B2
(en)
|
1998-04-30 |
2013-01-15 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8357091B2
(en)
|
1998-04-30 |
2013-01-22 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US9042953B2
(en)
|
1998-04-30 |
2015-05-26 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US9066694B2
(en)
|
1998-04-30 |
2015-06-30 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8275439B2
(en)
|
1998-04-30 |
2012-09-25 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US9066697B2
(en)
|
1998-04-30 |
2015-06-30 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US9072477B2
(en)
|
1998-04-30 |
2015-07-07 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US20090181100A1
(en)
*
|
1998-11-12 |
2009-07-16 |
Elan Pharma International Ltd |
Dry powder aerosols of Nanoparticulate drugs
|
US8124057B2
(en)
*
|
1998-11-12 |
2012-02-28 |
Alkermes Pharma Ireland Limited |
Propellant-based nanoparticulate dry powder aerosols and method of making
|
US20040157815A1
(en)
*
|
1999-09-11 |
2004-08-12 |
Smithkline Beecham Corporation |
Pharmaceutical formulation of fluticasone propionate
|
US20030059474A1
(en)
*
|
1999-10-18 |
2003-03-27 |
Scott Terrence L. |
Sustained release microspheres
|
US20050048001A1
(en)
*
|
1999-11-23 |
2005-03-03 |
Cripps Alan Leslie |
Pharmaceutical formulations of salmeterol
|
US20030032632A1
(en)
*
|
1999-12-24 |
2003-02-13 |
Crispps Leslie Alan |
Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
|
US20090142407A1
(en)
*
|
2000-09-01 |
2009-06-04 |
Meda Pharama Gmbh & Co. Kg |
Solid peptide preparations for inhalation and their preparation
|
US7374782B2
(en)
|
2000-10-27 |
2008-05-20 |
Baxter International Inc. |
Production of microspheres
|
US9011332B2
(en)
|
2001-01-02 |
2015-04-21 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8668645B2
(en)
|
2001-01-02 |
2014-03-11 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US9498159B2
(en)
|
2001-01-02 |
2016-11-22 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US9610034B2
(en)
|
2001-01-02 |
2017-04-04 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8652043B2
(en)
|
2001-01-02 |
2014-02-18 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8765059B2
(en)
|
2001-04-02 |
2014-07-01 |
Abbott Diabetes Care Inc. |
Blood glucose tracking apparatus
|
US7976778B2
(en)
|
2001-04-02 |
2011-07-12 |
Abbott Diabetes Care Inc. |
Blood glucose tracking apparatus
|
US8236242B2
(en)
|
2001-04-02 |
2012-08-07 |
Abbott Diabetes Care Inc. |
Blood glucose tracking apparatus and methods
|
US9477811B2
(en)
|
2001-04-02 |
2016-10-25 |
Abbott Diabetes Care Inc. |
Blood glucose tracking apparatus and methods
|
US8268243B2
(en)
|
2001-04-02 |
2012-09-18 |
Abbott Diabetes Care Inc. |
Blood glucose tracking apparatus and methods
|
US7449173B2
(en)
|
2001-05-24 |
2008-11-11 |
Alexza Pharmaceuticals, Inc. |
Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route
|
US20040185005A1
(en)
*
|
2001-05-24 |
2004-09-23 |
Alexza Molecular Delivery Corporation |
Delivery of antiemetics through an inhalation route
|
WO2002094245A1
(en)
*
|
2001-05-24 |
2002-11-28 |
Alexza Molecular Delivery Corporation |
Delivery of antihistamines through an inhalation route
|
US10350157B2
(en)
|
2001-05-24 |
2019-07-16 |
Alexza Pharmaceuticals, Inc. |
Drug condensation aerosols and kits
|
US7169378B2
(en)
|
2001-05-24 |
2007-01-30 |
Alexza Pharmaceuticals, Inc. |
Delivery of opioids through an inhalation route
|
US6740308B2
(en)
|
2001-05-24 |
2004-05-25 |
Alexza Molecular Delivery Corporation |
Delivery of antihistamines through an inhalation route
|
US20040126327A1
(en)
*
|
2001-05-24 |
2004-07-01 |
Alexza Molecular Delivery Corporation |
Delivery of nonsteroidal antiinflammatory drugs through an inhalation route
|
US20040126328A1
(en)
*
|
2001-05-24 |
2004-07-01 |
Alexza Molecular Delivery Corporation |
Delivery of compounds for the treatment of migraine through an inhalation route
|
US20040127481A1
(en)
*
|
2001-05-24 |
2004-07-01 |
Alexza Molecular Delivery Corporation |
Delivery of anti-migraine compounds through an inhalation route
|
US20040126326A1
(en)
*
|
2001-05-24 |
2004-07-01 |
Alexza Molecular Delivery Corporation |
Delivery of antidepressants through an inhalation route
|
US20040126329A1
(en)
*
|
2001-05-24 |
2004-07-01 |
Alexza Molecular Delivery Corporation |
Delivery of analgesics through an inhalation route
|
US20060233719A1
(en)
*
|
2001-05-24 |
2006-10-19 |
Alexza Pharmaceuticals, Inc. |
Delivery of antidepressants through an inhalation route
|
US20040127490A1
(en)
*
|
2001-05-24 |
2004-07-01 |
Alexza Molecular Delivery Corporation |
Delivery of alprazolam, estazolam midazolam or triazolam through an inhalation route
|
US7115250B2
(en)
|
2001-05-24 |
2006-10-03 |
Alexza Pharmaceuticals, Inc. |
Delivery of erectile dysfunction drugs through an inhalation route
|
US20040156788A1
(en)
*
|
2001-05-24 |
2004-08-12 |
Alexza Molecular Delivery Corporation |
Delivery of erectile dysfunction drugs through an inhalation route
|
US7108847B2
(en)
|
2001-05-24 |
2006-09-19 |
Alexza Pharmaceuticals, Inc. |
Delivery of muscle relaxants through an inhalation route
|
US20040161385A1
(en)
*
|
2001-05-24 |
2004-08-19 |
Alexza Molecular Delivery Corporation |
Delivery of beta-blockers through an inhalation route
|
US9440034B2
(en)
|
2001-05-24 |
2016-09-13 |
Alexza Pharmaceuticals, Inc. |
Drug condensation aerosols and kits
|
US20040167228A1
(en)
*
|
2001-05-24 |
2004-08-26 |
Alexza Molecular Delivery Corporation |
Delivery of beta-blockers through an inhalation route
|
US7442368B2
(en)
|
2001-05-24 |
2008-10-28 |
Alexza Pharmaceuticals, Inc. |
Delivery of stimulants through an inhalation route
|
US7445768B2
(en)
|
2001-05-24 |
2008-11-04 |
Alexza Pharmaceuticals, Inc. |
Delivery of sedative-hypnotics through an inhalation route
|
US7449175B2
(en)
|
2001-05-24 |
2008-11-11 |
Alexza Pharmaceuticals, Inc. |
Delivery of erectile dysfunction drugs through an inhalation route
|
US7449172B2
(en)
|
2001-05-24 |
2008-11-11 |
Alexza Pharmaceuticals, Inc. |
Delivery of antiemetics through an inhalation route
|
US7449174B2
(en)
|
2001-05-24 |
2008-11-11 |
Alexza Pharmaceuticals, Inc. |
Delivery of analgesics through an inhalation route
|
US7094392B2
(en)
|
2001-05-24 |
2006-08-22 |
Alexza Pharmaceuticals, Inc. |
Delivery of antihistamines through an inhalation route
|
US20040170570A1
(en)
*
|
2001-05-24 |
2004-09-02 |
Alexza Molecular Delivery Corporation |
Delivery of rizatriptan or zolmitriptan through an inhalation route
|
US7090830B2
(en)
|
2001-05-24 |
2006-08-15 |
Alexza Pharmaceuticals, Inc. |
Drug condensation aerosols and kits
|
US20040170573A1
(en)
*
|
2001-05-24 |
2004-09-02 |
Alexza Molecular Delivery Corporation |
Delivery of sumatriptan, frovatriptan or naratriptan through an inhalation route
|
US7465435B2
(en)
|
2001-05-24 |
2008-12-16 |
Alexza Pharmaceuticals, Inc. |
Delivery of beta-blockers through an inhalation route
|
US7465437B2
(en)
|
2001-05-24 |
2008-12-16 |
Alexza Pharmaceuticals, Inc. |
Delivery of anti-migraine compounds through an inhalation route
|
US7465436B2
(en)
|
2001-05-24 |
2008-12-16 |
Alexza Pharmaceuticals, Inc. |
Delivery of compounds for the treatment of Parkinson's through an inhalation route
|
US7468179B2
(en)
|
2001-05-24 |
2008-12-23 |
Alexza Pharmaceuticals, Inc. |
Delivery of opioids through an inhalation route
|
US20040170572A1
(en)
*
|
2001-05-24 |
2004-09-02 |
Alexza Molecular Delivery Corporation |
Delivery of rizatriptan or zolmitriptan through an inhalation route
|
US7485285B2
(en)
|
2001-05-24 |
2009-02-03 |
Alexza Pharmaceuticals, Inc. |
Delivery of antidepressants through an inhalation route
|
US7491047B2
(en)
|
2001-05-24 |
2009-02-17 |
Alexza Pharmaceuticals, Inc. |
Delivery of antihistamines through an inhalation route
|
US7087216B2
(en)
|
2001-05-24 |
2006-08-08 |
Rabinowitz Joshua D |
Delivery of sedative-hypnotics through an inhalation route
|
US7498019B2
(en)
|
2001-05-24 |
2009-03-03 |
Alexza Pharmaceuticals, Inc. |
Delivery of compounds for the treatment of headache through an inhalation route
|
US7507397B2
(en)
|
2001-05-24 |
2009-03-24 |
Alexza Pharmaceuticals, Inc. |
Delivery of muscle relaxants through an inhalation route
|
US7510702B2
(en)
|
2001-05-24 |
2009-03-31 |
Alexza Pharmaceuticals, Inc. |
Delivery of nonsteroidal antiinflammatory drugs through an inhalation route
|
US20040185000A1
(en)
*
|
2001-05-24 |
2004-09-23 |
Alexza Molecular Delivery Corporation |
Delivery of antihistamines through an inhalation route
|
US20040185006A1
(en)
*
|
2001-05-24 |
2004-09-23 |
Alexza Molecular Delivery Corporation |
Delivery of stimulants through an inhalation route
|
US7524484B2
(en)
|
2001-05-24 |
2009-04-28 |
Alexza Pharmaceuticals, Inc. |
Delivery of diphenhydramine through an inhalation route
|
US20040184996A1
(en)
*
|
2001-05-24 |
2004-09-23 |
Alexza Molecular Delivery Corporation |
Delivery of nonsteroidal antiinflammatory drugs through an inhalation route
|
US20040185004A1
(en)
*
|
2001-05-24 |
2004-09-23 |
Alexza Molecular Delivery Corporation |
Delivery of erectile dysfunction drugs through an inhalation route
|
US7087217B2
(en)
|
2001-05-24 |
2006-08-08 |
Alexza Pharmaceuticals, Inc. |
Delivery of nonsteroidal antiinflammatory drugs through an inhalation route
|
US7078018B2
(en)
|
2001-05-24 |
2006-07-18 |
Alexza Pharmaceuticals, Inc. |
Delivery of opioids through an inhalation route
|
US20040185007A1
(en)
*
|
2001-05-24 |
2004-09-23 |
Alexza Molecular Delivery Corporation |
Delivery of compounds for the treatment of Parkinsons through an inhalation route
|
US7078019B2
(en)
|
2001-05-24 |
2006-07-18 |
Alexza Pharmaceuticals, Inc. |
Delivery of drug esters through an inhalation route
|
US9211382B2
(en)
|
2001-05-24 |
2015-12-15 |
Alexza Pharmaceuticals, Inc. |
Drug condensation aerosols and kits
|
US7078017B2
(en)
|
2001-05-24 |
2006-07-18 |
Alexza Pharmaceuticals, Inc. |
Delivery of sedative-hypnotics through an inhalation route
|
US20040185008A1
(en)
*
|
2001-05-24 |
2004-09-23 |
Alexza Molecular Delivery Corporation |
Delivery of compounds for the treatment of parkinsons through an inhalation route
|
US7078020B2
(en)
|
2001-05-24 |
2006-07-18 |
Alexza Pharmaceuticals, Inc. |
Delivery of antipsychotics through an inhalation route
|
US20040184999A1
(en)
*
|
2001-05-24 |
2004-09-23 |
Alexza Molecular Delivery Corporation |
Delivery of anti-migraine compounds through an inhalation route
|
US7585493B2
(en)
|
2001-05-24 |
2009-09-08 |
Alexza Pharmaceuticals, Inc. |
Thin-film drug delivery article and method of use
|
US7070766B2
(en)
|
2001-05-24 |
2006-07-04 |
Alexza Pharmaceuticals, Inc. |
Delivery of physiologically active compounds through an inhalation route
|
US20040185003A1
(en)
*
|
2001-05-24 |
2004-09-23 |
Alexza Molecular Delivery Corporation |
Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route
|
US7601337B2
(en)
|
2001-05-24 |
2009-10-13 |
Alexza Pharmaceuticals, Inc. |
Delivery of antipsychotics through an inhalation route
|
US7070763B2
(en)
|
2001-05-24 |
2006-07-04 |
Alexza Pharmaceuticals, Inc. |
Delivery of diphenhydramine through an inhalation route
|
US7070764B2
(en)
|
2001-05-24 |
2006-07-04 |
Alexza Pharmaceuticals, Inc. |
Delivery of analgesics through an inhalation route
|
US7645442B2
(en)
|
2001-05-24 |
2010-01-12 |
Alexza Pharmaceuticals, Inc. |
Rapid-heating drug delivery article and method of use
|
US7070762B2
(en)
|
2001-05-24 |
2006-07-04 |
Alexza Pharmaceuticals, Inc. |
Delivery of analgesics through an inhalation route
|
US20060286042A1
(en)
*
|
2001-05-24 |
2006-12-21 |
Alexza Pharmaceuticals, Inc. |
Delivery of sedative-hypnotics through an inhalation route
|
US7070761B2
(en)
|
2001-05-24 |
2006-07-04 |
Alexza Pharmaceuticals, Inc. |
Delivery of nonsteroidal antiinflammatory drugs through an inhalation route
|
US7070765B2
(en)
|
2001-05-24 |
2006-07-04 |
Alexza Pharmaceuticals, Inc. |
Delivery of drug esters through an inhalation route
|
US8235037B2
(en)
|
2001-05-24 |
2012-08-07 |
Alexza Pharmaceuticals, Inc. |
Drug condensation aerosols and kits
|
US7067114B2
(en)
|
2001-05-24 |
2006-06-27 |
Alexza Pharmaceuticals, Inc. |
Delivery of antihistamines through an inhalation route
|
US20040185001A1
(en)
*
|
2001-05-24 |
2004-09-23 |
Alexza Molecular Delivery Corporation |
Delivery of physiologically active compounds through an inhalation route
|
US7063830B2
(en)
|
2001-05-24 |
2006-06-20 |
Alexza Pharmaceuticals, Inc. |
Delivery of anti-migraine compounds through an inhalation route
|
US20040186130A1
(en)
*
|
2001-05-24 |
2004-09-23 |
Alexza Molecular Delivery Corporation |
Delivery of muscle relaxants through an inhalation route
|
US20040191179A1
(en)
*
|
2001-05-24 |
2004-09-30 |
Alexza Molecular Delivery Corporation |
Delivery of antidepressants through an inhalation route
|
US7063831B2
(en)
|
2001-05-24 |
2006-06-20 |
Alexza Pharmaceuticals, Inc. |
Delivery of erectile dysfunction drugs through an inhalation route
|
US7063832B2
(en)
|
2001-05-24 |
2006-06-20 |
Alexza Pharmaceuticals, Inc. |
Delivery of muscle relaxants through an inhalation route
|
US7060254B2
(en)
|
2001-05-24 |
2006-06-13 |
Alexza Pharmaceuticals, Inc. |
Delivery of antidepressants through an inhalation route
|
US7060255B2
(en)
|
2001-05-24 |
2006-06-13 |
Alexza Pharmaceuticals, Inc. |
Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route
|
US7052679B2
(en)
|
2001-05-24 |
2006-05-30 |
Alexza Pharmaceuticals, Inc. |
Delivery of antipsychotics through an inhalation route
|
US20040191183A1
(en)
*
|
2001-05-24 |
2004-09-30 |
Alexza Molecular Delivery Corporation |
Delivery of antiemetics through an inhalation route
|
US7052680B2
(en)
|
2001-05-24 |
2006-05-30 |
Alexza Pharmaceuticals, Inc. |
Delivery of compounds for the treatment of Parkinsons through an inhalation route
|
US20040191181A1
(en)
*
|
2001-05-24 |
2004-09-30 |
Alexza Molecular Delivery Corporation |
Delivery of diphenhydramine through an inhalation route
|
US20040191182A1
(en)
*
|
2001-05-24 |
2004-09-30 |
Alexza Molecular Delivery Corporation |
Delivery of analgesics through an inhalation route
|
US7048909B2
(en)
|
2001-05-24 |
2006-05-23 |
Alexza Pharmaceuticals, Inc. |
Delivery of beta-blockers through an inhalation route
|
US7045118B2
(en)
|
2001-05-24 |
2006-05-16 |
Alexza Pharmaceuticals, Inc. |
Delivery of compounds for the treatment of migraine through an inhalation route
|
US20040191180A1
(en)
*
|
2001-05-24 |
2004-09-30 |
Alexza Molecular Delivery Corporation |
Delivery of compounds for the treatment of migraine through an inhalation route
|
US20040202617A1
(en)
*
|
2001-05-24 |
2004-10-14 |
Alexza Molecular Delivery Corporation |
Delivery of opioids through an inhalation route
|
US6994843B2
(en)
|
2001-05-24 |
2006-02-07 |
Alexza Pharmaceuticals, Inc. |
Delivery of stimulants through an inhalation route
|
US7005121B2
(en)
|
2001-05-24 |
2006-02-28 |
Alexza Pharmaceuticals, Inc. |
Delivery of compounds for the treatment of migraine through an inhalation route
|
US7005122B2
(en)
|
2001-05-24 |
2006-02-28 |
Alexza Pharmaceutical, Inc. |
Delivery of sumatriptan, frovatriptan or naratriptan through an inhalation route
|
US7008616B2
(en)
|
2001-05-24 |
2006-03-07 |
Alexza Pharmaceuticals, Inc. |
Delivery of stimulants through an inhalation route
|
US7008615B2
(en)
|
2001-05-24 |
2006-03-07 |
Alexza Pharmaceuticals, Inc. |
Delivery of anti-migraine compounds through an inhalation route
|
US8173107B2
(en)
|
2001-05-24 |
2012-05-08 |
Alexza Pharmaceuticals, Inc. |
Delivery of antipsychotics through an inhalation route
|
US7011819B2
(en)
|
2001-05-24 |
2006-03-14 |
Alexza Pharmaceuticals, Inc. |
Delivery of rizatriptan or zolmitriptan through an inhalation route
|
US7011820B2
(en)
|
2001-05-24 |
2006-03-14 |
Alexza Pharmaceuticals, Inc. |
Delivery of compounds for the treatment of Parkinsons through an inhalation route
|
US7033575B2
(en)
|
2001-05-24 |
2006-04-25 |
Alexza Pharmaceuticals, Inc. |
Delivery of physiologically active compounds through an inhalation route
|
US7014841B2
(en)
|
2001-05-24 |
2006-03-21 |
Alexza Pharmaceuticals, Inc. |
Delivery of antiemetics through an inhalation route
|
US7014840B2
(en)
|
2001-05-24 |
2006-03-21 |
Alexza Pharmaceuticals, Inc. |
Delivery of sumatriptan, frovatriptan or naratriptan through an inhalation route
|
US7018620B2
(en)
|
2001-05-24 |
2006-03-28 |
Alexza Pharmaceuticals, Inc. |
Delivery of beta-blockers through an inhalation route
|
US7018619B2
(en)
|
2001-05-24 |
2006-03-28 |
Alexza Pharmaceuticals, Inc. |
Delivery of alprazolam, estazolam midazolam or triazolam through an inhalation route
|
US7029658B2
(en)
|
2001-05-24 |
2006-04-18 |
Alexza Pharmaceuticals, Inc. |
Delivery of antidepressants through an inhalation route
|
US7018621B2
(en)
|
2001-05-24 |
2006-03-28 |
Alexza Pharmaceuticals, Inc. |
Delivery of rizatriptan or zolmitriptan through an inhalation route
|
US7022312B2
(en)
|
2001-05-24 |
2006-04-04 |
Alexza Pharmaceuticals, Inc. |
Delivery of antiemetics through an inhalation route
|
US7988952B2
(en)
|
2001-05-24 |
2011-08-02 |
Alexza Pharmaceuticals, Inc. |
Delivery of drug esters through an inhalation route
|
US9439907B2
(en)
|
2001-06-05 |
2016-09-13 |
Alexza Pharmaceutical, Inc. |
Method of forming an aerosol for inhalation delivery
|
US9308208B2
(en)
|
2001-06-05 |
2016-04-12 |
Alexza Pharmaceuticals, Inc. |
Aerosol generating method and device
|
US7766013B2
(en)
|
2001-06-05 |
2010-08-03 |
Alexza Pharmaceuticals, Inc. |
Aerosol generating method and device
|
US8074644B2
(en)
|
2001-06-05 |
2011-12-13 |
Alexza Pharmaceuticals, Inc. |
Method of forming an aerosol for inhalation delivery
|
US8955512B2
(en)
|
2001-06-05 |
2015-02-17 |
Alexza Pharmaceuticals, Inc. |
Method of forming an aerosol for inhalation delivery
|
US7942147B2
(en)
|
2001-06-05 |
2011-05-17 |
Alexza Pharmaceuticals, Inc. |
Aerosol forming device for use in inhalation therapy
|
US11065400B2
(en)
|
2001-06-05 |
2021-07-20 |
Alexza Pharmaceuticals, Inc. |
Aerosol forming device for use in inhalation therapy
|
US7537009B2
(en)
|
2001-06-05 |
2009-05-26 |
Alexza Pharmaceuticals, Inc. |
Method of forming an aerosol for inhalation delivery
|
US9687487B2
(en)
|
2001-06-05 |
2017-06-27 |
Alexza Pharmaceuticals, Inc. |
Aerosol forming device for use in inhalation therapy
|
EP1406592A2
(en)
*
|
2001-07-18 |
2004-04-14 |
Aeropharm Technology Incorporated |
A salt/ion pair medicinal aerosol formulation
|
EP1406592A4
(en)
*
|
2001-07-18 |
2010-03-17 |
Aeropharm Technology Inc |
MEDICAL AEROSOL FORMULATION WITH PAIR SALT / ION
|
US20030064033A1
(en)
*
|
2001-08-16 |
2003-04-03 |
Brown Larry R. |
Propellant-based microparticle formulations
|
EP1944016A1
(en)
|
2001-08-16 |
2008-07-16 |
Baxter International Inc. |
Propellant-based microparticle formulatons
|
WO2003015750A1
(en)
*
|
2001-08-16 |
2003-02-27 |
Baxter International, Inc. |
Propellant-based microparticle formulations
|
US20040170571A1
(en)
*
|
2001-11-09 |
2004-09-02 |
Alexza Molecular Delivery Corporation |
Delivery of diazepam through an inhalation route
|
US20060269486A1
(en)
*
|
2001-11-09 |
2006-11-30 |
Alexza Pharmaceuticals, Inc. |
Delivery of diazepam through an inhalation route
|
US7470421B2
(en)
|
2001-11-09 |
2008-12-30 |
Alexza Pharmaceuticals, Inc |
Delivery of diazepam through an inhalation route
|
US7087218B2
(en)
|
2001-11-09 |
2006-08-08 |
Alexza Pharmaceuticals, Inc. |
Delivery of diazepam through an inhalation route
|
US20040171609A1
(en)
*
|
2001-11-09 |
2004-09-02 |
Alexza Molecular Delivery Corporation |
Delivery of diazepam through an inhalation route
|
US7045119B2
(en)
|
2001-11-09 |
2006-05-16 |
Alexza Pharmaceuticals, Inc. |
Delivery of diazepam through an inhalation route
|
US9282925B2
(en)
|
2002-02-12 |
2016-03-15 |
Dexcom, Inc. |
Systems and methods for replacing signal artifacts in a glucose sensor data stream
|
US20080107741A1
(en)
*
|
2002-03-20 |
2008-05-08 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of angiogenesis inhibitors
|
US20080279949A1
(en)
*
|
2002-03-20 |
2008-11-13 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of angiogenesis inhibitors
|
US8470301B2
(en)
|
2002-04-17 |
2013-06-25 |
Nektar Therapeutics |
Particulate materials
|
US7582284B2
(en)
|
2002-04-17 |
2009-09-01 |
Nektar Therapeutics |
Particulate materials
|
US10251881B2
(en)
|
2002-04-17 |
2019-04-09 |
Nektar Therapeutics |
Particulate materials
|
US8828359B2
(en)
|
2002-04-17 |
2014-09-09 |
Nektar Therapeutics |
Particulate materials
|
US9616060B2
(en)
|
2002-04-17 |
2017-04-11 |
Nektar Therapeutics |
Particulate materials
|
US8080236B2
(en)
|
2002-04-17 |
2011-12-20 |
Nektar Therapeutics Uk, Ltd |
Particulate materials
|
US7987846B2
(en)
|
2002-05-13 |
2011-08-02 |
Alexza Pharmaceuticals, Inc. |
Method and apparatus for vaporizing a compound
|
US8003080B2
(en)
|
2002-05-13 |
2011-08-23 |
Alexza Pharmaceuticals, Inc. |
Delivery of drug amines through an inhalation route
|
US7458374B2
(en)
|
2002-05-13 |
2008-12-02 |
Alexza Pharmaceuticals, Inc. |
Method and apparatus for vaporizing a compound
|
US8506935B2
(en)
|
2002-11-26 |
2013-08-13 |
Alexza Pharmaceuticals, Inc. |
Respiratory drug condensation aerosols and methods of making and using them
|
US7981401B2
(en)
|
2002-11-26 |
2011-07-19 |
Alexza Pharmaceuticals, Inc. |
Diuretic aerosols and methods of making and using them
|
US8288372B2
(en)
|
2002-11-26 |
2012-10-16 |
Alexza Pharmaceuticals, Inc. |
Method for treating headache with loxapine
|
US7550133B2
(en)
|
2002-11-26 |
2009-06-23 |
Alexza Pharmaceuticals, Inc. |
Respiratory drug condensation aerosols and methods of making and using them
|
US7913688B2
(en)
|
2002-11-27 |
2011-03-29 |
Alexza Pharmaceuticals, Inc. |
Inhalation device for producing a drug aerosol
|
US9370629B2
(en)
|
2003-05-21 |
2016-06-21 |
Alexza Pharmaceuticals, Inc. |
Self-contained heating unit and drug-supply unit employing same
|
US8991387B2
(en)
|
2003-05-21 |
2015-03-31 |
Alexza Pharmaceuticals, Inc. |
Self-contained heating unit and drug-supply unit employing same
|
US8387612B2
(en)
|
2003-05-21 |
2013-03-05 |
Alexza Pharmaceuticals, Inc. |
Self-contained heating unit and drug-supply unit employing same
|
US7896809B2
(en)
|
2003-07-25 |
2011-03-01 |
Dexcom, Inc. |
Dual electrode system for a continuous analyte sensor
|
US8260393B2
(en)
|
2003-07-25 |
2012-09-04 |
Dexcom, Inc. |
Systems and methods for replacing signal data artifacts in a glucose sensor data stream
|
US8423113B2
(en)
|
2003-07-25 |
2013-04-16 |
Dexcom, Inc. |
Systems and methods for processing sensor data
|
US7955261B2
(en)
|
2003-08-01 |
2011-06-07 |
Dexcom, Inc. |
System and methods for processing analyte sensor data
|
US8160669B2
(en)
|
2003-08-01 |
2012-04-17 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US7599726B2
(en)
|
2003-08-01 |
2009-10-06 |
Dexcom, Inc. |
System and methods for processing analyte sensor data
|
US7778680B2
(en)
|
2003-08-01 |
2010-08-17 |
Dexcom, Inc. |
System and methods for processing analyte sensor data
|
US7797028B2
(en)
|
2003-08-01 |
2010-09-14 |
Dexcom, Inc. |
System and methods for processing analyte sensor data
|
US7826981B2
(en)
|
2003-08-01 |
2010-11-02 |
Dexcom, Inc. |
System and methods for processing analyte sensor data
|
US8986209B2
(en)
|
2003-08-01 |
2015-03-24 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US7914450B2
(en)
|
2003-08-01 |
2011-03-29 |
Dexcom, Inc. |
System and methods for processing analyte sensor data
|
US8915849B2
(en)
|
2003-08-01 |
2014-12-23 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US8676287B2
(en)
|
2003-08-01 |
2014-03-18 |
Dexcom, Inc. |
System and methods for processing analyte sensor data
|
US8275437B2
(en)
|
2003-08-01 |
2012-09-25 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US8206297B2
(en)
|
2003-08-01 |
2012-06-26 |
Dexcom, Inc. |
System and methods for processing analyte sensor data
|
US8886273B2
(en)
|
2003-08-01 |
2014-11-11 |
Dexcom, Inc. |
Analyte sensor
|
US8622905B2
(en)
|
2003-08-01 |
2014-01-07 |
Dexcom, Inc. |
System and methods for processing analyte sensor data
|
US7925321B2
(en)
|
2003-08-01 |
2011-04-12 |
Dexcom, Inc. |
System and methods for processing analyte sensor data
|
US8285354B2
(en)
|
2003-08-01 |
2012-10-09 |
Dexcom, Inc. |
System and methods for processing analyte sensor data
|
US8700117B2
(en)
|
2003-08-01 |
2014-04-15 |
Dexcom, Inc. |
System and methods for processing analyte sensor data
|
US7933639B2
(en)
|
2003-08-01 |
2011-04-26 |
Dexcom, Inc. |
System and methods for processing analyte sensor data
|
US8845536B2
(en)
|
2003-08-01 |
2014-09-30 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US8588882B2
(en)
|
2003-08-01 |
2013-11-19 |
Dexcom, Inc. |
System and methods for processing analyte sensor data
|
US7959569B2
(en)
|
2003-08-01 |
2011-06-14 |
Dexcom, Inc. |
System and methods for processing analyte sensor data
|
US8548553B2
(en)
|
2003-08-01 |
2013-10-01 |
Dexcom, Inc. |
System and methods for processing analyte sensor data
|
US8290562B2
(en)
|
2003-08-01 |
2012-10-16 |
Dexcom, Inc. |
System and methods for processing analyte sensor data
|
US7583990B2
(en)
|
2003-08-01 |
2009-09-01 |
Dexcom, Inc. |
System and methods for processing analyte sensor data
|
US7979104B2
(en)
|
2003-08-01 |
2011-07-12 |
Dexcom, Inc. |
System and methods for processing analyte sensor data
|
US8761856B2
(en)
|
2003-08-01 |
2014-06-24 |
Dexcom, Inc. |
System and methods for processing analyte sensor data
|
US8311749B2
(en)
|
2003-08-01 |
2012-11-13 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US8321149B2
(en)
|
2003-08-01 |
2012-11-27 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US8332008B2
(en)
|
2003-08-01 |
2012-12-11 |
Dexcom, Inc. |
System and methods for processing analyte sensor data
|
US8771187B2
(en)
|
2003-08-01 |
2014-07-08 |
Dexcom, Inc. |
System and methods for processing analyte sensor data
|
US7986986B2
(en)
|
2003-08-01 |
2011-07-26 |
Dexcom, Inc. |
System and methods for processing analyte sensor data
|
US8774888B2
(en)
|
2003-08-01 |
2014-07-08 |
Dexcom, Inc. |
System and methods for processing analyte sensor data
|
US8060173B2
(en)
|
2003-08-01 |
2011-11-15 |
Dexcom, Inc. |
System and methods for processing analyte sensor data
|
US8052601B2
(en)
|
2003-08-01 |
2011-11-08 |
Dexcom, Inc. |
System and methods for processing analyte sensor data
|
US9895089B2
(en)
|
2003-08-01 |
2018-02-20 |
Dexcom, Inc. |
System and methods for processing analyte sensor data
|
US8788006B2
(en)
|
2003-08-01 |
2014-07-22 |
Dexcom, Inc. |
System and methods for processing analyte sensor data
|
US8788007B2
(en)
|
2003-08-01 |
2014-07-22 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US8369919B2
(en)
|
2003-08-01 |
2013-02-05 |
Dexcom, Inc. |
Systems and methods for processing sensor data
|
US8442610B2
(en)
|
2003-08-01 |
2013-05-14 |
Dexcom, Inc. |
System and methods for processing analyte sensor data
|
US8788008B2
(en)
|
2003-08-01 |
2014-07-22 |
Dexcom, Inc. |
System and methods for processing analyte sensor data
|
US8000901B2
(en)
|
2003-08-01 |
2011-08-16 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US8428679B2
(en)
|
2003-08-01 |
2013-04-23 |
Dexcom, Inc. |
System and methods for processing analyte sensor data
|
US10786185B2
(en)
|
2003-08-01 |
2020-09-29 |
Dexcom, Inc. |
System and methods for processing analyte sensor data
|
US8801612B2
(en)
|
2003-08-01 |
2014-08-12 |
Dexcom, Inc. |
System and methods for processing analyte sensor data
|
US8808182B2
(en)
|
2003-08-01 |
2014-08-19 |
Dexcom, Inc. |
System and methods for processing analyte sensor data
|
US8394021B2
(en)
|
2003-08-01 |
2013-03-12 |
Dexcom, Inc. |
System and methods for processing analyte sensor data
|
US9247901B2
(en)
|
2003-08-22 |
2016-02-02 |
Dexcom, Inc. |
Systems and methods for replacing signal artifacts in a glucose sensor data stream
|
US8412301B2
(en)
|
2003-08-22 |
2013-04-02 |
Dexcom, Inc. |
Systems and methods for replacing signal artifacts in a glucose sensor data stream
|
US8195265B2
(en)
|
2003-08-22 |
2012-06-05 |
Dexcom, Inc. |
Systems and methods for replacing signal artifacts in a glucose sensor data stream
|
US11589823B2
(en)
|
2003-08-22 |
2023-02-28 |
Dexcom, Inc. |
Systems and methods for replacing signal artifacts in a glucose sensor data stream
|
US8150488B2
(en)
|
2003-08-22 |
2012-04-03 |
Dexcom, Inc. |
Systems and methods for replacing signal artifacts in a glucose sensor data stream
|
US8672845B2
(en)
|
2003-08-22 |
2014-03-18 |
Dexcom, Inc. |
Systems and methods for processing analyte sensor data
|
US8435179B2
(en)
|
2003-08-22 |
2013-05-07 |
Dexcom, Inc. |
Systems and methods for replacing signal artifacts in a glucose sensor data stream
|
US8128562B2
(en)
|
2003-08-22 |
2012-03-06 |
Dexcom, Inc. |
Systems and methods for replacing signal artifacts in a glucose sensor data stream
|
US11559260B2
(en)
|
2003-08-22 |
2023-01-24 |
Dexcom, Inc. |
Systems and methods for processing analyte sensor data
|
US8229536B2
(en)
|
2003-08-22 |
2012-07-24 |
Dexcom, Inc. |
Systems and methods for replacing signal artifacts in a glucose sensor data stream
|
US8073520B2
(en)
|
2003-08-22 |
2011-12-06 |
Dexcom, Inc. |
Systems and methods for replacing signal artifacts in a glucose sensor data stream
|
US8346338B2
(en)
|
2003-08-22 |
2013-01-01 |
Dexcom, Inc. |
System and methods for replacing signal artifacts in a glucose sensor data stream
|
US9750460B2
(en)
|
2003-08-22 |
2017-09-05 |
Dexcom, Inc. |
Systems and methods for replacing signal artifacts in a glucose sensor data stream
|
US9724045B1
(en)
|
2003-08-22 |
2017-08-08 |
Dexcom, Inc. |
Systems and methods for replacing signal artifacts in a glucose sensor data stream
|
US8073519B2
(en)
|
2003-08-22 |
2011-12-06 |
Dexcom, Inc. |
Systems and methods for replacing signal artifacts in a glucose sensor data stream
|
US9649069B2
(en)
|
2003-08-22 |
2017-05-16 |
Dexcom, Inc. |
Systems and methods for replacing signal artifacts in a glucose sensor data stream
|
US8292810B2
(en)
|
2003-08-22 |
2012-10-23 |
Dexcom, Inc. |
Systems and methods for replacing signal artifacts in a glucose sensor data stream
|
US8491474B2
(en)
|
2003-08-22 |
2013-07-23 |
Dexcom, Inc. |
Systems and methods for replacing signal artifacts in a glucose sensor data stream
|
US8777853B2
(en)
|
2003-08-22 |
2014-07-15 |
Dexcom, Inc. |
Systems and methods for replacing signal artifacts in a glucose sensor data stream
|
US9585607B2
(en)
|
2003-08-22 |
2017-03-07 |
Dexcom, Inc. |
Systems and methods for replacing signal artifacts in a glucose sensor data stream
|
US8010174B2
(en)
|
2003-08-22 |
2011-08-30 |
Dexcom, Inc. |
Systems and methods for replacing signal artifacts in a glucose sensor data stream
|
US9510782B2
(en)
|
2003-08-22 |
2016-12-06 |
Dexcom, Inc. |
Systems and methods for replacing signal artifacts in a glucose sensor data stream
|
US9427183B2
(en)
|
2003-08-22 |
2016-08-30 |
Dexcom, Inc. |
Systems and methods for replacing signal artifacts in a glucose sensor data stream
|
US9420968B2
(en)
|
2003-08-22 |
2016-08-23 |
Dexcom, Inc. |
Systems and methods for replacing signal artifacts in a glucose sensor data stream
|
US8233959B2
(en)
|
2003-08-22 |
2012-07-31 |
Dexcom, Inc. |
Systems and methods for processing analyte sensor data
|
US9149219B2
(en)
|
2003-08-22 |
2015-10-06 |
Dexcom, Inc. |
Systems and methods for replacing signal artifacts in a glucose sensor data stream
|
US8657747B2
(en)
|
2003-08-22 |
2014-02-25 |
Dexcom, Inc. |
Systems and methods for processing analyte sensor data
|
US20100179407A1
(en)
*
|
2003-08-22 |
2010-07-15 |
Dexcom, Inc. |
Systems and methods for replacing signal artifacts in a glucose sensor data stream
|
US8167801B2
(en)
|
2003-08-22 |
2012-05-01 |
Dexcom, Inc. |
Systems and methods for replacing signal artifacts in a glucose sensor data stream
|
US8005525B2
(en)
|
2003-08-22 |
2011-08-23 |
Dexcom, Inc. |
Systems and methods for replacing signal artifacts in a glucose sensor data stream
|
US7935057B2
(en)
|
2003-08-22 |
2011-05-03 |
Dexcom, Inc. |
Systems and methods for replacing signal artifacts in a glucose sensor data stream
|
US8843187B2
(en)
|
2003-08-22 |
2014-09-23 |
Dexcom, Inc. |
Systems and methods for replacing signal artifacts in a glucose sensor data stream
|
US8821400B2
(en)
|
2003-08-22 |
2014-09-02 |
Dexcom, Inc. |
Systems and methods for replacing signal artifacts in a glucose sensor data stream
|
US8812073B2
(en)
|
2003-08-22 |
2014-08-19 |
Dexcom, Inc. |
Systems and methods for replacing signal artifacts in a glucose sensor data stream
|
US7998071B2
(en)
|
2003-08-22 |
2011-08-16 |
Dexcom, Inc. |
Systems and methods for replacing signal artifacts in a glucose sensor data stream
|
US8790260B2
(en)
|
2003-08-22 |
2014-07-29 |
Dexcom, Inc. |
Systems and methods for replacing signal artifacts in a glucose sensor data stream
|
US8795177B2
(en)
|
2003-08-22 |
2014-08-05 |
Dexcom, Inc. |
Systems and methods for replacing signal artifacts in a glucose sensor data stream
|
US7519408B2
(en)
|
2003-11-19 |
2009-04-14 |
Dexcom, Inc. |
Integrated receiver for continuous analyte sensor
|
US8282550B2
(en)
|
2003-11-19 |
2012-10-09 |
Dexcom, Inc. |
Integrated receiver for continuous analyte sensor
|
US7927274B2
(en)
|
2003-11-19 |
2011-04-19 |
Dexcom, Inc. |
Integrated receiver for continuous analyte sensor
|
US11564602B2
(en)
|
2003-11-19 |
2023-01-31 |
Dexcom, Inc. |
Integrated receiver for continuous analyte sensor
|
US9538946B2
(en)
|
2003-11-19 |
2017-01-10 |
Dexcom, Inc. |
Integrated receiver for continuous analyte sensor
|
US8249684B2
(en)
|
2003-12-05 |
2012-08-21 |
Dexcom, Inc. |
Calibration techniques for a continuous analyte sensor
|
US7715893B2
(en)
|
2003-12-05 |
2010-05-11 |
Dexcom, Inc. |
Calibration techniques for a continuous analyte sensor
|
USRE44695E1
(en)
|
2003-12-05 |
2014-01-07 |
Dexcom, Inc. |
Dual electrode system for a continuous analyte sensor
|
US8287453B2
(en)
|
2003-12-05 |
2012-10-16 |
Dexcom, Inc. |
Analyte sensor
|
US8483793B2
(en)
|
2003-12-05 |
2013-07-09 |
Dexcom, Inc. |
Dual electrode system for a continuous analyte sensor
|
US11000215B1
(en)
|
2003-12-05 |
2021-05-11 |
Dexcom, Inc. |
Analyte sensor
|
US11020031B1
(en)
|
2003-12-05 |
2021-06-01 |
Dexcom, Inc. |
Analyte sensor
|
US7917186B2
(en)
|
2003-12-05 |
2011-03-29 |
Dexcom, Inc. |
Calibration techniques for a continuous analyte sensor
|
US8386004B2
(en)
|
2003-12-05 |
2013-02-26 |
Dexcom, Inc. |
Calibration techniques for a continuous analyte sensor
|
US8428678B2
(en)
|
2003-12-05 |
2013-04-23 |
Dexcom, Inc. |
Calibration techniques for a continuous analyte sensor
|
US11633133B2
(en)
|
2003-12-05 |
2023-04-25 |
Dexcom, Inc. |
Dual electrode system for a continuous analyte sensor
|
US8160671B2
(en)
|
2003-12-05 |
2012-04-17 |
Dexcom, Inc. |
Calibration techniques for a continuous analyte sensor
|
US8005524B2
(en)
|
2003-12-09 |
2011-08-23 |
Dexcom, Inc. |
Signal processing for continuous analyte sensor
|
US8801610B2
(en)
|
2003-12-09 |
2014-08-12 |
Dexcom, Inc. |
Signal processing for continuous analyte sensor
|
US11638541B2
(en)
|
2003-12-09 |
2023-05-02 |
Dexconi, Inc. |
Signal processing for continuous analyte sensor
|
US8374667B2
(en)
|
2003-12-09 |
2013-02-12 |
Dexcom, Inc. |
Signal processing for continuous analyte sensor
|
US9107623B2
(en)
|
2003-12-09 |
2015-08-18 |
Dexcom, Inc. |
Signal processing for continuous analyte sensor
|
US9192328B2
(en)
|
2003-12-09 |
2015-11-24 |
Dexcom, Inc. |
Signal processing for continuous analyte sensor
|
US9351668B2
(en)
|
2003-12-09 |
2016-05-31 |
Dexcom, Inc. |
Signal processing for continuous analyte sensor
|
US9364173B2
(en)
|
2003-12-09 |
2016-06-14 |
Dexcom, Inc. |
Signal processing for continuous analyte sensor
|
US8747315B2
(en)
|
2003-12-09 |
2014-06-10 |
Dexcom. Inc. |
Signal processing for continuous analyte sensor
|
US8216139B2
(en)
|
2003-12-09 |
2012-07-10 |
Dexcom, Inc. |
Signal processing for continuous analyte sensor
|
US10898113B2
(en)
|
2003-12-09 |
2021-01-26 |
Dexcom, Inc. |
Signal processing for continuous analyte sensor
|
US9420965B2
(en)
|
2003-12-09 |
2016-08-23 |
Dexcom, Inc. |
Signal processing for continuous analyte sensor
|
US8233958B2
(en)
|
2003-12-09 |
2012-07-31 |
Dexcom, Inc. |
Signal processing for continuous analyte sensor
|
US9498155B2
(en)
|
2003-12-09 |
2016-11-22 |
Dexcom, Inc. |
Signal processing for continuous analyte sensor
|
US8469886B2
(en)
|
2003-12-09 |
2013-06-25 |
Dexcom, Inc. |
Signal processing for continuous analyte sensor
|
US8657745B2
(en)
|
2003-12-09 |
2014-02-25 |
Dexcom, Inc. |
Signal processing for continuous analyte sensor
|
US8251906B2
(en)
|
2003-12-09 |
2012-08-28 |
Dexcom, Inc. |
Signal processing for continuous analyte sensor
|
US8257259B2
(en)
|
2003-12-09 |
2012-09-04 |
Dexcom, Inc. |
Signal processing for continuous analyte sensor
|
US8290561B2
(en)
|
2003-12-09 |
2012-10-16 |
Dexcom, Inc. |
Signal processing for continuous analyte sensor
|
US9750441B2
(en)
|
2003-12-09 |
2017-09-05 |
Dexcom, Inc. |
Signal processing for continuous analyte sensor
|
US8265725B2
(en)
|
2003-12-09 |
2012-09-11 |
Dexcom, Inc. |
Signal processing for continuous analyte sensor
|
US8282549B2
(en)
|
2003-12-09 |
2012-10-09 |
Dexcom, Inc. |
Signal processing for continuous analyte sensor
|
US10159752B2
(en)
|
2003-12-31 |
2018-12-25 |
Cydex Pharmaceuticals, Inc. |
Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
|
EP1718276A2
(en)
*
|
2003-12-31 |
2006-11-08 |
Cydex Inc. |
Inhalant formulation containing sulfoalkylether cyclodextrin and corticosteroid prepared from a unit dose suspension
|
US20070020299A1
(en)
*
|
2003-12-31 |
2007-01-25 |
Pipkin James D |
Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
|
EP1732512A4
(en)
*
|
2003-12-31 |
2008-07-23 |
Cydex Inc |
SULFOALKYL ETHERCYCLODEXTRIN AND CORTICOSTEROID CONTAINING INHALATION SUBSTANCE MOLORING
|
US10207008B2
(en)
|
2003-12-31 |
2019-02-19 |
Cydex Pharmaceuticals, Inc. |
Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
|
EP1718276A4
(en)
*
|
2003-12-31 |
2008-07-23 |
Cydex Inc |
INHALATION FORMULATION CONTAINING SULFOALKYL ETHER CYCLODEXTRIN AND CORTICOSTEROID BASED ON SUSPENSION IN UNIT DOSES
|
US20070202054A1
(en)
*
|
2003-12-31 |
2007-08-30 |
Pipkin James D |
Inhalant Formulation Containing Sulfoalkyl Ether Cyclodextrin and Corticosteroid
|
US10799599B2
(en)
|
2003-12-31 |
2020-10-13 |
Cydex Pharmaceuticals, Inc. |
Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
|
EP1732512A2
(en)
*
|
2003-12-31 |
2006-12-20 |
Cydex Inc. |
Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
|
US20070020196A1
(en)
*
|
2003-12-31 |
2007-01-25 |
Pipkin James D |
Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid prepared from a unit dose suspension
|
US9827324B2
(en)
|
2003-12-31 |
2017-11-28 |
Cydex Pharmaceuticals, Inc. |
Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
|
US7637868B2
(en)
|
2004-01-12 |
2009-12-29 |
Dexcom, Inc. |
Composite material for implantable device
|
US8920401B2
(en)
|
2004-02-26 |
2014-12-30 |
Dexcom, Inc. |
Integrated delivery device for continuous glucose sensor
|
US7591801B2
(en)
*
|
2004-02-26 |
2009-09-22 |
Dexcom, Inc. |
Integrated delivery device for continuous glucose sensor
|
US7976492B2
(en)
|
2004-02-26 |
2011-07-12 |
Dexcom, Inc. |
Integrated delivery device for continuous glucose sensor
|
US8882741B2
(en)
|
2004-02-26 |
2014-11-11 |
Dexcom, Inc. |
Integrated delivery device for continuous glucose sensor
|
US8721585B2
(en)
|
2004-02-26 |
2014-05-13 |
Dex Com, Inc. |
Integrated delivery device for continuous glucose sensor
|
US9937293B2
(en)
|
2004-02-26 |
2018-04-10 |
Dexcom, Inc. |
Integrated delivery device for continuous glucose sensor
|
US9050413B2
(en)
|
2004-02-26 |
2015-06-09 |
Dexcom, Inc. |
Integrated delivery device for continuous glucose sensor
|
US11246990B2
(en)
|
2004-02-26 |
2022-02-15 |
Dexcom, Inc. |
Integrated delivery device for continuous glucose sensor
|
US8808228B2
(en)
|
2004-02-26 |
2014-08-19 |
Dexcom, Inc. |
Integrated medicament delivery device for use with continuous analyte sensor
|
US8926585B2
(en)
|
2004-02-26 |
2015-01-06 |
Dexcom, Inc. |
Integrated delivery device for continuous glucose sensor
|
US10835672B2
(en)
|
2004-02-26 |
2020-11-17 |
Dexcom, Inc. |
Integrated insulin delivery system with continuous glucose sensor
|
US10278580B2
(en)
|
2004-02-26 |
2019-05-07 |
Dexcom, Inc. |
Integrated medicament delivery device for use with continuous analyte sensor
|
US10966609B2
(en)
|
2004-02-26 |
2021-04-06 |
Dexcom, Inc. |
Integrated medicament delivery device for use with continuous analyte sensor
|
US8460231B2
(en)
|
2004-02-26 |
2013-06-11 |
Dexcom, Inc. |
Integrated delivery device for continuous glucose sensor
|
US9155843B2
(en)
|
2004-02-26 |
2015-10-13 |
Dexcom, Inc. |
Integrated delivery device for continuous glucose sensor
|
US9833143B2
(en)
|
2004-05-03 |
2017-12-05 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US10327638B2
(en)
|
2004-05-03 |
2019-06-25 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US7657297B2
(en)
|
2004-05-03 |
2010-02-02 |
Dexcom, Inc. |
Implantable analyte sensor
|
US8792955B2
(en)
|
2004-05-03 |
2014-07-29 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US7540286B2
(en)
|
2004-06-03 |
2009-06-02 |
Alexza Pharmaceuticals, Inc. |
Multiple dose condensation aerosol devices and methods of forming condensation aerosols
|
US8333197B2
(en)
|
2004-06-03 |
2012-12-18 |
Alexza Pharmaceuticals, Inc. |
Multiple dose condensation aerosol devices and methods of forming condensation aerosols
|
US9775543B2
(en)
|
2004-07-13 |
2017-10-03 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US10993641B2
(en)
|
2004-07-13 |
2021-05-04 |
Dexcom, Inc. |
Analyte sensor
|
US9055901B2
(en)
|
2004-07-13 |
2015-06-16 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US9044199B2
(en)
|
2004-07-13 |
2015-06-02 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US7640048B2
(en)
|
2004-07-13 |
2009-12-29 |
Dexcom, Inc. |
Analyte sensor
|
US8565849B2
(en)
|
2004-07-13 |
2013-10-22 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US11883164B2
(en)
|
2004-07-13 |
2024-01-30 |
Dexcom, Inc. |
System and methods for processing analyte sensor data for sensor calibration
|
US8731630B2
(en)
|
2004-07-13 |
2014-05-20 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US8170803B2
(en)
|
2004-07-13 |
2012-05-01 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US8690775B2
(en)
|
2004-07-13 |
2014-04-08 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US11064917B2
(en)
|
2004-07-13 |
2021-07-20 |
Dexcom, Inc. |
Analyte sensor
|
US11045120B2
(en)
|
2004-07-13 |
2021-06-29 |
Dexcom, Inc. |
Analyte sensor
|
US11026605B1
(en)
|
2004-07-13 |
2021-06-08 |
Dexcom, Inc. |
Analyte sensor
|
US8463350B2
(en)
|
2004-07-13 |
2013-06-11 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US9060742B2
(en)
|
2004-07-13 |
2015-06-23 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US8571625B2
(en)
|
2004-07-13 |
2013-10-29 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US7783333B2
(en)
|
2004-07-13 |
2010-08-24 |
Dexcom, Inc. |
Transcutaneous medical device with variable stiffness
|
US10993642B2
(en)
|
2004-07-13 |
2021-05-04 |
Dexcom, Inc. |
Analyte sensor
|
US10980452B2
(en)
|
2004-07-13 |
2021-04-20 |
Dexcom, Inc. |
Analyte sensor
|
US8750955B2
(en)
|
2004-07-13 |
2014-06-10 |
Dexcom, Inc. |
Analyte sensor
|
US7857760B2
(en)
|
2004-07-13 |
2010-12-28 |
Dexcom, Inc. |
Analyte sensor
|
US8565848B2
(en)
|
2004-07-13 |
2013-10-22 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US10932700B2
(en)
|
2004-07-13 |
2021-03-02 |
Dexcom, Inc. |
Analyte sensor
|
US10918313B2
(en)
|
2004-07-13 |
2021-02-16 |
Dexcom, Inc. |
Analyte sensor
|
US10918315B2
(en)
|
2004-07-13 |
2021-02-16 |
Dexcom, Inc. |
Analyte sensor
|
US10918314B2
(en)
|
2004-07-13 |
2021-02-16 |
Dexcom, Inc. |
Analyte sensor
|
US10827956B2
(en)
|
2004-07-13 |
2020-11-10 |
Dexcom, Inc. |
Analyte sensor
|
US7885697B2
(en)
|
2004-07-13 |
2011-02-08 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US7899511B2
(en)
|
2004-07-13 |
2011-03-01 |
Dexcom, Inc. |
Low oxygen in vivo analyte sensor
|
US7905833B2
(en)
|
2004-07-13 |
2011-03-15 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US9414777B2
(en)
|
2004-07-13 |
2016-08-16 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US10813576B2
(en)
|
2004-07-13 |
2020-10-27 |
Dexcom, Inc. |
Analyte sensor
|
US10799159B2
(en)
|
2004-07-13 |
2020-10-13 |
Dexcom, Inc. |
Analyte sensor
|
US10799158B2
(en)
|
2004-07-13 |
2020-10-13 |
Dexcom, Inc. |
Analyte sensor
|
US8231531B2
(en)
|
2004-07-13 |
2012-07-31 |
Dexcom, Inc. |
Analyte sensor
|
US8663109B2
(en)
|
2004-07-13 |
2014-03-04 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US10722152B2
(en)
|
2004-07-13 |
2020-07-28 |
Dexcom, Inc. |
Analyte sensor
|
US10709363B2
(en)
|
2004-07-13 |
2020-07-14 |
Dexcom, Inc. |
Analyte sensor
|
US10709362B2
(en)
|
2004-07-13 |
2020-07-14 |
Dexcom, Inc. |
Analyte sensor
|
US10524703B2
(en)
|
2004-07-13 |
2020-01-07 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US8792953B2
(en)
|
2004-07-13 |
2014-07-29 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US8792954B2
(en)
|
2004-07-13 |
2014-07-29 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US8548551B2
(en)
|
2004-07-13 |
2013-10-01 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US8290560B2
(en)
|
2004-07-13 |
2012-10-16 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US8515516B2
(en)
|
2004-07-13 |
2013-08-20 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US8280475B2
(en)
|
2004-07-13 |
2012-10-02 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US8812072B2
(en)
|
2004-07-13 |
2014-08-19 |
Dexcom, Inc. |
Transcutaneous medical device with variable stiffness
|
US8483791B2
(en)
|
2004-07-13 |
2013-07-09 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US9986942B2
(en)
|
2004-07-13 |
2018-06-05 |
Dexcom, Inc. |
Analyte sensor
|
US8825127B2
(en)
|
2004-07-13 |
2014-09-02 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US7949381B2
(en)
|
2004-07-13 |
2011-05-24 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US9801572B2
(en)
|
2004-07-13 |
2017-10-31 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US8858434B2
(en)
|
2004-07-13 |
2014-10-14 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US7581540B2
(en)
|
2004-08-12 |
2009-09-01 |
Alexza Pharmaceuticals, Inc. |
Aerosol drug delivery device incorporating percussively activated heat packages
|
US8579816B2
(en)
|
2005-03-10 |
2013-11-12 |
Dexcom, Inc. |
System and methods for processing analyte sensor data for sensor calibration
|
US7920906B2
(en)
|
2005-03-10 |
2011-04-05 |
Dexcom, Inc. |
System and methods for processing analyte sensor data for sensor calibration
|
US9220449B2
(en)
|
2005-03-10 |
2015-12-29 |
Dexcom, Inc. |
System and methods for processing analyte sensor data for sensor calibration
|
US10610137B2
(en)
|
2005-03-10 |
2020-04-07 |
Dexcom, Inc. |
System and methods for processing analyte sensor data for sensor calibration
|
US10925524B2
(en)
|
2005-03-10 |
2021-02-23 |
Dexcom, Inc. |
System and methods for processing analyte sensor data for sensor calibration
|
US9078608B2
(en)
|
2005-03-10 |
2015-07-14 |
Dexcom, Inc. |
System and methods for processing analyte sensor data for sensor calibration
|
US10918316B2
(en)
|
2005-03-10 |
2021-02-16 |
Dexcom, Inc. |
System and methods for processing analyte sensor data for sensor calibration
|
US10918317B2
(en)
|
2005-03-10 |
2021-02-16 |
Dexcom, Inc. |
System and methods for processing analyte sensor data for sensor calibration
|
US10918318B2
(en)
|
2005-03-10 |
2021-02-16 |
Dexcom, Inc. |
System and methods for processing analyte sensor data for sensor calibration
|
US11000213B2
(en)
|
2005-03-10 |
2021-05-11 |
Dexcom, Inc. |
System and methods for processing analyte sensor data for sensor calibration
|
US10898114B2
(en)
|
2005-03-10 |
2021-01-26 |
Dexcom, Inc. |
System and methods for processing analyte sensor data for sensor calibration
|
US9918668B2
(en)
|
2005-03-10 |
2018-03-20 |
Dexcom, Inc. |
System and methods for processing analyte sensor data for sensor calibration
|
US10856787B2
(en)
|
2005-03-10 |
2020-12-08 |
Dexcom, Inc. |
System and methods for processing analyte sensor data for sensor calibration
|
US11051726B2
(en)
|
2005-03-10 |
2021-07-06 |
Dexcom, Inc. |
System and methods for processing analyte sensor data for sensor calibration
|
US8560037B2
(en)
|
2005-03-10 |
2013-10-15 |
Dexcom, Inc. |
System and methods for processing analyte sensor data for sensor calibration
|
US10743801B2
(en)
|
2005-03-10 |
2020-08-18 |
Dexcom, Inc. |
System and methods for processing analyte sensor data for sensor calibration
|
US10610135B2
(en)
|
2005-03-10 |
2020-04-07 |
Dexcom, Inc. |
System and methods for processing analyte sensor data for sensor calibration
|
US10709364B2
(en)
|
2005-03-10 |
2020-07-14 |
Dexcom, Inc. |
System and methods for processing analyte sensor data for sensor calibration
|
US10624539B2
(en)
|
2005-03-10 |
2020-04-21 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US10617336B2
(en)
|
2005-03-10 |
2020-04-14 |
Dexcom, Inc. |
System and methods for processing analyte sensor data for sensor calibration
|
US8611978B2
(en)
|
2005-03-10 |
2013-12-17 |
Dexcom, Inc. |
System and methods for processing analyte sensor data for sensor calibration
|
US10610102B2
(en)
|
2005-03-10 |
2020-04-07 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US10716498B2
(en)
|
2005-03-10 |
2020-07-21 |
Dexcom, Inc. |
System and methods for processing analyte sensor data for sensor calibration
|
US9314196B2
(en)
|
2005-03-10 |
2016-04-19 |
Dexcom, Inc. |
System and methods for processing analyte sensor data for sensor calibration
|
US10610136B2
(en)
|
2005-03-10 |
2020-04-07 |
Dexcom, Inc. |
System and methods for processing analyte sensor data for sensor calibration
|
US10813577B2
(en)
|
2005-06-21 |
2020-10-27 |
Dexcom, Inc. |
Analyte sensor
|
US10709332B2
(en)
|
2005-06-21 |
2020-07-14 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US10610103B2
(en)
|
2005-06-21 |
2020-04-07 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US8367734B1
(en)
|
2005-08-11 |
2013-02-05 |
Amphastar Pharmaceuticals Inc. |
Stable epinephrine suspension formulation with high inhalation delivery efficiency
|
US11103165B2
(en)
|
2005-11-01 |
2021-08-31 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US9078607B2
(en)
|
2005-11-01 |
2015-07-14 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8915850B2
(en)
|
2005-11-01 |
2014-12-23 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US10952652B2
(en)
|
2005-11-01 |
2021-03-23 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US11911151B1
(en)
|
2005-11-01 |
2024-02-27 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US11363975B2
(en)
|
2005-11-01 |
2022-06-21 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US9326716B2
(en)
|
2005-11-01 |
2016-05-03 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US11399748B2
(en)
|
2005-11-01 |
2022-08-02 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8920319B2
(en)
|
2005-11-01 |
2014-12-30 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US10201301B2
(en)
|
2005-11-01 |
2019-02-12 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US10231654B2
(en)
|
2005-11-01 |
2019-03-19 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US11272867B2
(en)
|
2005-11-01 |
2022-03-15 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US20070197487A1
(en)
*
|
2005-12-20 |
2007-08-23 |
Verus Pharmaceuticals, Inc. |
Systems and methods for the delivery of corticosteroids having an increased lung deposition
|
US20070185066A1
(en)
*
|
2005-12-20 |
2007-08-09 |
Verus Pharmaceuticals, Inc. |
Systems and methods for the delivery of corticosteroids
|
US20070178049A1
(en)
*
|
2005-12-20 |
2007-08-02 |
Verus Pharmaceuticals, Inc. |
Systems and methods for the delivery of corticosteroids having an enhanced pharmacokinetic profile
|
US20070178050A1
(en)
*
|
2005-12-20 |
2007-08-02 |
Verus Pharmaceuticals, Inc. |
Methods and systems for the delivery of corticosteroids having an increased lung depositon
|
US20070160542A1
(en)
*
|
2005-12-20 |
2007-07-12 |
Verus Pharmaceuticals, Inc. |
Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile
|
US20070249572A1
(en)
*
|
2005-12-20 |
2007-10-25 |
Verus Pharmaceuticals, Inc. |
Systems and methods for the delivery of corticosteroids
|
US20070197486A1
(en)
*
|
2005-12-20 |
2007-08-23 |
Verus Pharmaceuticals, Inc. |
Methods and systems for the delivery of corticosteroids
|
US11191458B2
(en)
|
2006-01-17 |
2021-12-07 |
Dexcom, Inc. |
Low oxygen in vivo analyte sensor
|
US10265000B2
(en)
|
2006-01-17 |
2019-04-23 |
Dexcom, Inc. |
Low oxygen in vivo analyte sensor
|
US9757061B2
(en)
|
2006-01-17 |
2017-09-12 |
Dexcom, Inc. |
Low oxygen in vivo analyte sensor
|
US11596332B2
(en)
|
2006-01-17 |
2023-03-07 |
Dexcom, Inc. |
Low oxygen in vivo analyte sensor
|
US9724028B2
(en)
|
2006-02-22 |
2017-08-08 |
Dexcom, Inc. |
Analyte sensor
|
US7920907B2
(en)
|
2006-06-07 |
2011-04-05 |
Abbott Diabetes Care Inc. |
Analyte monitoring system and method
|
US20090191134A1
(en)
*
|
2006-06-12 |
2009-07-30 |
Medispray Laboratoriespvt. Ltd. |
Stable aerosol pharmaceutical formulations
|
US11432772B2
(en)
|
2006-08-02 |
2022-09-06 |
Dexcom, Inc. |
Systems and methods for replacing signal artifacts in a glucose sensor data stream
|
US10349873B2
(en)
|
2006-10-04 |
2019-07-16 |
Dexcom, Inc. |
Analyte sensor
|
US9451908B2
(en)
|
2006-10-04 |
2016-09-27 |
Dexcom, Inc. |
Analyte sensor
|
US11382539B2
(en)
|
2006-10-04 |
2022-07-12 |
Dexcom, Inc. |
Analyte sensor
|
US11399745B2
(en)
|
2006-10-04 |
2022-08-02 |
Dexcom, Inc. |
Dual electrode system for a continuous analyte sensor
|
US9833451B2
(en)
|
2007-02-11 |
2017-12-05 |
Map Pharmaceuticals, Inc. |
Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
|
US10172853B2
(en)
|
2007-02-11 |
2019-01-08 |
Map Pharmaceuticals, Inc. |
Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
|
US8119639B2
(en)
|
2007-02-11 |
2012-02-21 |
Map Pharmaceuticals, Inc. |
Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
|
US8148377B2
(en)
|
2007-02-11 |
2012-04-03 |
Map Pharmaceuticals, Inc. |
Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
|
US20080287451A1
(en)
*
|
2007-02-11 |
2008-11-20 |
Cook Robert O |
Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
|
US7994197B2
(en)
|
2007-02-11 |
2011-08-09 |
Map Pharmaceuticals, Inc. |
Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
|
US11642473B2
(en)
|
2007-03-09 |
2023-05-09 |
Alexza Pharmaceuticals, Inc. |
Heating unit for use in a drug delivery device
|
US10403012B2
(en)
|
2007-06-08 |
2019-09-03 |
Dexcom, Inc. |
Integrated medicament delivery device for use with continuous analyte sensor
|
US9741139B2
(en)
|
2007-06-08 |
2017-08-22 |
Dexcom, Inc. |
Integrated medicament delivery device for use with continuous analyte sensor
|
US11373347B2
(en)
|
2007-06-08 |
2022-06-28 |
Dexcom, Inc. |
Integrated medicament delivery device for use with continuous analyte sensor
|
US8562558B2
(en)
|
2007-06-08 |
2013-10-22 |
Dexcom, Inc. |
Integrated medicament delivery device for use with continuous analyte sensor
|
US9668682B2
(en)
|
2007-09-13 |
2017-06-06 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US11672422B2
(en)
|
2007-09-13 |
2023-06-13 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US12016648B2
(en)
|
2007-09-13 |
2024-06-25 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US9451910B2
(en)
|
2007-09-13 |
2016-09-27 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US11160926B1
(en)
|
2007-10-09 |
2021-11-02 |
Dexcom, Inc. |
Pre-connected analyte sensors
|
US10653835B2
(en)
|
2007-10-09 |
2020-05-19 |
Dexcom, Inc. |
Integrated insulin delivery system with continuous glucose sensor
|
US11744943B2
(en)
|
2007-10-09 |
2023-09-05 |
Dexcom, Inc. |
Integrated insulin delivery system with continuous glucose sensor
|
US8597616B2
(en)
*
|
2007-10-22 |
2013-12-03 |
Board Of Regents Of The University Of Texas System |
Dry powder drug delivery formulations, methods of use, and devices therefore
|
US20120111324A1
(en)
*
|
2007-10-22 |
2012-05-10 |
Board Of Regents, The University Of Texas System |
Dry Powder Drug Delivery Formulations, Methods of Use, and Devices Therefore
|
US10182751B2
(en)
|
2007-10-25 |
2019-01-22 |
Dexcom, Inc. |
Systems and methods for processing sensor data
|
US8417312B2
(en)
|
2007-10-25 |
2013-04-09 |
Dexcom, Inc. |
Systems and methods for processing sensor data
|
US11272869B2
(en)
|
2007-10-25 |
2022-03-15 |
Dexcom, Inc. |
Systems and methods for processing sensor data
|
US9717449B2
(en)
|
2007-10-25 |
2017-08-01 |
Dexcom, Inc. |
Systems and methods for processing sensor data
|
US20090140851A1
(en)
*
|
2007-12-04 |
2009-06-04 |
Nortel Networks Limited |
Systems and methods for facilitating a first response mission at an incident scene using patient monitoring
|
US9149233B2
(en)
|
2007-12-17 |
2015-10-06 |
Dexcom, Inc. |
Systems and methods for processing sensor data
|
US9149234B2
(en)
|
2007-12-17 |
2015-10-06 |
Dexcom, Inc. |
Systems and methods for processing sensor data
|
US9339238B2
(en)
|
2007-12-17 |
2016-05-17 |
Dexcom, Inc. |
Systems and methods for processing sensor data
|
US10827980B2
(en)
|
2007-12-17 |
2020-11-10 |
Dexcom, Inc. |
Systems and methods for processing sensor data
|
US10506982B2
(en)
|
2007-12-17 |
2019-12-17 |
Dexcom, Inc. |
Systems and methods for processing sensor data
|
US9135402B2
(en)
|
2007-12-17 |
2015-09-15 |
Dexcom, Inc. |
Systems and methods for processing sensor data
|
US8290559B2
(en)
|
2007-12-17 |
2012-10-16 |
Dexcom, Inc. |
Systems and methods for processing sensor data
|
US9901307B2
(en)
|
2007-12-17 |
2018-02-27 |
Dexcom, Inc. |
Systems and methods for processing sensor data
|
US9839395B2
(en)
|
2007-12-17 |
2017-12-12 |
Dexcom, Inc. |
Systems and methods for processing sensor data
|
US11342058B2
(en)
|
2007-12-17 |
2022-05-24 |
Dexcom, Inc. |
Systems and methods for processing sensor data
|
US11102306B2
(en)
|
2008-02-21 |
2021-08-24 |
Dexcom, Inc. |
Systems and methods for processing, transmitting and displaying sensor data
|
US8591455B2
(en)
|
2008-02-21 |
2013-11-26 |
Dexcom, Inc. |
Systems and methods for customizing delivery of sensor data
|
US9020572B2
(en)
|
2008-02-21 |
2015-04-28 |
Dexcom, Inc. |
Systems and methods for processing, transmitting and displaying sensor data
|
US8229535B2
(en)
|
2008-02-21 |
2012-07-24 |
Dexcom, Inc. |
Systems and methods for blood glucose monitoring and alert delivery
|
US9143569B2
(en)
|
2008-02-21 |
2015-09-22 |
Dexcom, Inc. |
Systems and methods for processing, transmitting and displaying sensor data
|
US10602968B2
(en)
|
2008-03-25 |
2020-03-31 |
Dexcom, Inc. |
Analyte sensor
|
US11896374B2
(en)
|
2008-03-25 |
2024-02-13 |
Dexcom, Inc. |
Analyte sensor
|
US8396528B2
(en)
|
2008-03-25 |
2013-03-12 |
Dexcom, Inc. |
Analyte sensor
|
US10028683B2
(en)
|
2008-09-19 |
2018-07-24 |
Dexcom, Inc. |
Particle-containing membrane and particulate electrode for analyte sensors
|
US9339222B2
(en)
|
2008-09-19 |
2016-05-17 |
Dexcom, Inc. |
Particle-containing membrane and particulate electrode for analyte sensors
|
US10561352B2
(en)
|
2008-09-19 |
2020-02-18 |
Dexcom, Inc. |
Particle-containing membrane and particulate electrode for analyte sensors
|
US10028684B2
(en)
|
2008-09-19 |
2018-07-24 |
Dexcom, Inc. |
Particle-containing membrane and particulate electrode for analyte sensors
|
US11918354B2
(en)
|
2008-09-19 |
2024-03-05 |
Dexcom, Inc. |
Particle-containing membrane and particulate electrode for analyte sensors
|
US8560039B2
(en)
|
2008-09-19 |
2013-10-15 |
Dexcom, Inc. |
Particle-containing membrane and particulate electrode for analyte sensors
|
US10980461B2
(en)
|
2008-11-07 |
2021-04-20 |
Dexcom, Inc. |
Advanced analyte sensor calibration and error detection
|
US9446194B2
(en)
|
2009-03-27 |
2016-09-20 |
Dexcom, Inc. |
Methods and systems for promoting glucose management
|
US10675405B2
(en)
|
2009-03-27 |
2020-06-09 |
Dexcom, Inc. |
Methods and systems for simulating glucose response to simulated actions
|
US10537678B2
(en)
|
2009-03-27 |
2020-01-21 |
Dexcom, Inc. |
Methods and systems for promoting glucose management
|
US10610642B2
(en)
|
2009-03-27 |
2020-04-07 |
Dexcom, Inc. |
Methods and systems for promoting glucose management
|
US11706876B2
(en)
|
2017-10-24 |
2023-07-18 |
Dexcom, Inc. |
Pre-connected analyte sensors
|
US11331022B2
(en)
|
2017-10-24 |
2022-05-17 |
Dexcom, Inc. |
Pre-connected analyte sensors
|
US11350862B2
(en)
|
2017-10-24 |
2022-06-07 |
Dexcom, Inc. |
Pre-connected analyte sensors
|
US11943876B2
(en)
|
2017-10-24 |
2024-03-26 |
Dexcom, Inc. |
Pre-connected analyte sensors
|
US11382540B2
(en)
|
2017-10-24 |
2022-07-12 |
Dexcom, Inc. |
Pre-connected analyte sensors
|